IVD
Basic information
Region (hg38): 15:40405485-40435947
Links
Phenotypes
GenCC
Source:
- isovaleric acidemia (Definitive), mode of inheritance: AR
- isovaleric acidemia (Definitive), mode of inheritance: AR
- isovaleric acidemia (Strong), mode of inheritance: AR
- isovaleric acidemia (Supportive), mode of inheritance: AR
- isovaleric acidemia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Isovaleric acidemia | AR | Biochemical | Medical/dietary treatment (eg, with l-carnitine, glycine, and leucine restricted/low protein diet) can be effective; Specific measures can be taken to prevent severe sequelae of acute metabolic decompensation | Biochemical; Cardiovascular; Neurologic | 5229850; 4378266; 4166104; 692626; 6630517; 3863140; 3139936; 3137519; 2063866; 15486829; 20142522; 20301313; 20662350; 20807522; 21207059; 21335445; 22004070; 22350545; 22960500; 23063737 |
ClinVar
This is a list of variants' phenotypes submitted to
- Isovaleryl-CoA_dehydrogenase_deficiency (626 variants)
- not_provided (74 variants)
- not_specified (65 variants)
- Inborn_genetic_diseases (46 variants)
- IVD-related_disorder (17 variants)
- Isovaleric_acidemia,_type_I (2 variants)
- Isovaleric_acidemia,_type_III (1 variants)
- Intellectual_disability (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IVD gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002225.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 201 | 206 | ||||
missense | 62 | 139 | 211 | |||
nonsense | 12 | 11 | 23 | |||
start loss | 2 | 1 | 3 | |||
frameshift | 26 | 27 | 53 | |||
splice donor/acceptor (+/-2bp) | 27 | 36 | ||||
Total | 53 | 129 | 143 | 205 | 2 |
Highest pathogenic variant AF is 0.0009014
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IVD | protein_coding | protein_coding | ENST00000487418 | 12 | 30461 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.53e-14 | 0.0260 | 125683 | 0 | 65 | 125748 | 0.000258 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.349 | 231 | 246 | 0.937 | 0.0000148 | 2785 |
Missense in Polyphen | 82 | 107.9 | 0.75998 | 1199 | ||
Synonymous | 0.222 | 99 | 102 | 0.972 | 0.00000639 | 850 |
Loss of Function | 0.243 | 22 | 23.3 | 0.946 | 0.00000125 | 255 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000506 | 0.000506 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000217 | 0.000217 |
Finnish | 0.0000933 | 0.0000924 |
European (Non-Finnish) | 0.000308 | 0.000308 |
Middle Eastern | 0.000217 | 0.000217 |
South Asian | 0.000359 | 0.000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Disease
- DISEASE: Isovaleric acidemia (IVA) [MIM:243500]: A metabolic disorder characterized by retarded psychomotor development, a peculiar odor resembling sweaty feet, an aversion to dietary protein, and pernicious vomiting, leading to acidosis and coma. The acute neonatal form leads to massive metabolic acidosis from the first days of life and rapid death. {ECO:0000269|PubMed:2063866, ECO:0000269|PubMed:22004070, ECO:0000269|PubMed:22350545, ECO:0000269|PubMed:23587913, ECO:0000269|PubMed:28535199, ECO:0000269|PubMed:9665741}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Valine, leucine and isoleucine degradation - Homo sapiens (human);Valproic Acid Pathway, Pharmacokinetics;3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;Valproic Acid Metabolism Pathway;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Valproic acid pathway;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;leucine degradation;Metabolism;Valine, leucine and isoleucine degradation;Valine Leucine Isoleucine degradation
(Consensus)
Recessive Scores
- pRec
- 0.462
Intolerance Scores
- loftool
- 0.154
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.34
Haploinsufficiency Scores
- pHI
- 0.100
- hipred
- N
- hipred_score
- 0.393
- ghis
- 0.562
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.555
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ivd
- Phenotype
- homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- leucine catabolic process;branched-chain amino acid catabolic process;fatty acid beta-oxidation using acyl-CoA dehydrogenase
- Cellular component
- mitochondrion;mitochondrial matrix
- Molecular function
- protein binding;isovaleryl-CoA dehydrogenase activity;flavin adenine dinucleotide binding